Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09
A new drug designed to “seek and destroy” common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested. The Phase 1 clinical trial will help determine if EP–100 is safe and effective for use among patients with solid cancer tumors, with fewer side effects than chemotherapy or radiation treatment.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Study points way to development of drugs for deadly childhood leukemia
EurekAlert, 12/15/09
Painkiller undermines aspirins anti-clotting action
EurekAlert, 12/15/09
Tracking new cancer-killing particles with MRI
EurekAlert, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor